Takeda Pharma Sp. z o.o. secures contract for Pharmaceutical products - Successive deliveries of the Fruzaqla drug to the B4 drug program for SPZOZ Opole Oncology Center in Opole

Poland, July 8 -- Poland based Takeda Pharma Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu for Pharmaceutical products - Successive deliveries of the Fruzaqla drug to the B4 drug program for SPZOZ Opole Oncology Center in Opole . The value of the contract is worth 1389066.4 PLN .

Published by HT Digital Content Services with permission from Pivotal Sources....